BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

422 hedge funds and large institutions have $15.4B invested in BioMarin Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 66 funds opening new positions, 175 increasing their positions, 120 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
422
Holders Change
+31
Holders Change %
+7.93%
% of All Funds
11.28%
Holding in Top 10
13
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.35%
New
66
Increased
175
Reduced
120
Closed
32
Calls
$127M
Puts
$124M
Net Calls
+$3.04M
Net Calls Change
-$11.5M

Top Buyers

1
Capital Research Global Investors
Capital Research Global Investors
California
$1.87B
2
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
$75.4M
3
Vanguard Group
Vanguard Group
Pennsylvania
$1.13B
4
Invesco
Invesco
Georgia
$283M
5
Jennison Associates
Jennison Associates
New York
$898M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
$933M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$239M
3
Sands Capital Management
Sands Capital Management
Virginia
$946M
4
Citadel Advisors
Citadel Advisors
Florida
$90M
5
HM
HealthCor Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BCMIO
451
Beacon Capital Management Inc (Ohio)
Ohio
– -$8K -100 Closed
VIA
452
Vantage Investment Advisors
Pennsylvania
– -$6K -75 Closed
JIC
453
Joel Isaacson & Co
New York
– -$2K -28 Closed
GBT
454
Grove Bank & Trust
Florida
– -$2K -23 Closed
15 16 17 18
19